{"transactions":[{"id":2672185,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:35:45.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-040088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919121040088/doc4.xml","form_type":"4"}},{"id":2672184,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-11T20:35:45.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":29520,"source":{"system":"sec-edgar","filing":"0001209191-21-040088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919121040088/doc4.xml","form_type":"4"}},{"id":2674103,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-10T18:07:10.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":2600,"price":61.14,"value":158964.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.130 to $61.175, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote."}],"balance_after":23520,"source":{"system":"sec-edgar","filing":"0001209191-21-039610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919121039610/doc4.xml","form_type":"4"}},{"id":2681100,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-04T17:27:19.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":2380,"price":62.123,"value":147852.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":26120,"source":{"system":"sec-edgar","filing":"0001209191-21-038328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919121038328/doc4.xml","form_type":"4"}},{"id":3122296,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-04T16:48:23.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":71300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2021, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":71300,"derivative":{"exercise_price":43.58,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":71300},"source":{"system":"sec-edgar","filing":"0001209191-20-034450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919120034450/doc4.xml","form_type":"4"}},{"id":3122295,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-04T16:48:23.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 1, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001209191-20-034450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775268/000120919120034450/doc4.xml","form_type":"4"}},{"id":3536743,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-07T20:55:12.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":56407,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Shares of common stock of the corporation then known as Adynxx, Inc. (\"Private Adynxx\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 11, 2018, by and among the Issuer, Embark Merger Sub, Inc. and Private Adynxx (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.0359 shares of the Issuer's common stock, reflecting a reverse stock split at a ratio of one new share for every six shares of common stock outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(5) On December 16, 2016, Reporting Person was granted an option to purchase 1,571,214 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.11 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 56,407 shares of the Issuer's common stock at a per share exercise price of $3.06. Subject to Reporting Person's continued employment, 1/4th of the option vested and became exercisable on December 16, 2017 with the remainder vesting monthly thereafter for a total vesting period of 48 months. Upon a change of control of the Issuer, 100% of any unvested portion of the option will become fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(5) On December 16, 2016, Reporting Person was granted an option to purchase 1,571,214 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.11 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 56,407 shares of the Issuer's common stock at a per share exercise price of $3.06. Subject to Reporting Person's continued employment, 1/4th of the option vested and became exercisable on December 16, 2017 with the remainder vesting monthly thereafter for a total vesting period of 48 months. Upon a change of control of the Issuer, 100% of any unvested portion of the option will become fully vested and exercisable."}],"balance_after":56407,"derivative":{"exercise_price":3.06,"expiration_date":"2026-12-15","underlying":"Common Stock","underlying_shares":56407},"source":{"system":"sec-edgar","filing":"0001209191-19-028146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000120919119028146/doc4.xml","form_type":"4"}},{"id":3536742,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-07T20:55:12.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":3943,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Shares of common stock of the corporation then known as Adynxx, Inc. (\"Private Adynxx\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 11, 2018, by and among the Issuer, Embark Merger Sub, Inc. and Private Adynxx (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.0359 shares of the Issuer's common stock, reflecting a reverse stock split at a ratio of one new share for every six shares of common stock outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(4) On December 18, 2012, Reporting Person was granted an option to purchase 109,842 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.05 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 3,943 shares of the Issuer's common stock at a per share exercise price of $1.39. This option has fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(4) On December 18, 2012, Reporting Person was granted an option to purchase 109,842 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.05 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 3,943 shares of the Issuer's common stock at a per share exercise price of $1.39. This option has fully vested."}],"balance_after":3943,"derivative":{"exercise_price":1.39,"expiration_date":"2022-12-17","underlying":"Common Stock","underlying_shares":3943},"source":{"system":"sec-edgar","filing":"0001209191-19-028146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000120919119028146/doc4.xml","form_type":"4"}},{"id":3536741,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-07T20:55:12.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":7887,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Shares of common stock of the corporation then known as Adynxx, Inc. (\"Private Adynxx\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 11, 2018, by and among the Issuer, Embark Merger Sub, Inc. and Private Adynxx (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.0359 shares of the Issuer's common stock, reflecting a reverse stock split at a ratio of one new share for every six shares of common stock outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(3) On July 17, 2012, Reporting Person was granted an option to purchase 219,684 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.05 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,887 shares of the Issuer's common stock at a per share exercise price of $1.39. This option has fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(3) On July 17, 2012, Reporting Person was granted an option to purchase 219,684 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.05 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,887 shares of the Issuer's common stock at a per share exercise price of $1.39. This option has fully vested."}],"balance_after":7887,"derivative":{"exercise_price":1.39,"expiration_date":"2022-07-16","underlying":"Common Stock","underlying_shares":7887},"source":{"system":"sec-edgar","filing":"0001209191-19-028146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000120919119028146/doc4.xml","form_type":"4"}},{"id":3536740,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":138367,"kind":"person","name":"Manning Donald C.","position":1,"cik":"0001775268","reported_name":"Manning Donald C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-07T20:55:12.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":23858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Shares of common stock of the corporation then known as Adynxx, Inc. (\"Private Adynxx\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 11, 2018, by and among the Issuer, Embark Merger Sub, Inc. and Private Adynxx (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.0359 shares of the Issuer's common stock, reflecting a reverse stock split at a ratio of one new share for every six shares of common stock outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) On March 8, 2012, Reporting Person was granted an option to purchase 664,560 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.04 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 23,858 shares of the Issuer's common stock at a per share exercise price of $1.11. This option has fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(2) On March 8, 2012, Reporting Person was granted an option to purchase 664,560 shares of the common stock of Private Adynxx under Private Adynxx's Equity Incentive Plan at an exercise price of $0.04 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 23,858 shares of the Issuer's common stock at a per share exercise price of $1.11. This option has fully vested."}],"balance_after":23858,"derivative":{"exercise_price":1.11,"expiration_date":"2022-03-07","underlying":"Common Stock","underlying_shares":23858},"source":{"system":"sec-edgar","filing":"0001209191-19-028146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000120919119028146/doc4.xml","form_type":"4"}}]}